Supplementary data for the article: Milošević, E., Stanisavljević, N., Bošković, S., Stamenković, N., Novković, M., Bavelloni, A., Cenni, V., Kojić, S.,& Jasnić, J.. (2023). Antitumor activity of natural pigment violacein against osteosarcoma and rhabdomyosarcoma cell lines. in Journal of Cancer Research and Clinical Oncology. https://doi.org/10.1007/s00432-023-04930-9
Autori
Milošević, Emilija![](/themes/Mirageimagine/images/orcid.png)
Stanisavljević, Nemanja
![](/themes/Mirageimagine/images/orcid.png)
Bošković, Srđan
![](/themes/Mirageimagine/images/orcid.png)
Stamenković, Nemanja
Novković, Mirjana
![](/themes/Mirageimagine/images/orcid.png)
Bavelloni, Alberto
![](/themes/Mirageimagine/images/orcid.png)
Cenni, Vittoria
![](/themes/Mirageimagine/images/orcid.png)
Kojić, Snežana
![](/themes/Mirageimagine/images/orcid.png)
Jasnić, Jovana
![](/themes/Mirageimagine/images/orcid.png)
Skup podataka (Objavljena verzija)
![](/themes/Mirageimagine//images/creativecommons/arr.png)
Metapodaci
Prikaz svih podataka o dokumentuKljučne reči:
Anticancer / Natural compound / Osteosarcoma / Rhabdomyosarcoma / ViolaceinIzvor:
Journal of Cancer Research and Clinical Oncology, 2023Finansiranje / projekti:
- Kompleksne bolesti kao model sistem za proučavanje modulacije fenotipa-strukturna i funkcionalna analiza molekularnih biomarkera (RS-MESTD-Basic Research (BR or ON)-173008)
- Ministarstvo nauke, tehnološkog razvoja i inovacija Republike Srbije, institucionalno finansiranje - 200042 (Univerzitet u Beogradu, Institut za molekularnu genetiku i genetičko inženjerstvo) (RS-MESTD-inst-2020-200042)
- Ministarstvo nauke, tehnološkog razvoja i inovacija Republike Srbije, institucionalno finansiranje - 200042 (Univerzitet u Beogradu, Institut za molekularnu genetiku i genetičko inženjerstvo) (RS-MESTD-inst-2020-200042)
- Ministarstvo nauke, tehnološkog razvoja i inovacija Republike Srbije, institucionalno finansiranje - 200042 (Univerzitet u Beogradu, Institut za molekularnu genetiku i genetičko inženjerstvo) (RS-MESTD-inst-2020-200042)
Napomena:
- Supplementary material for: Milošević, E., Stanisavljević, N., Bošković, S., Stamenković, N., Novković, M., Bavelloni, A., Cenni, V., Kojić, S.,& Jasnić, J.. (2023). Antitumor activity of natural pigment violacein against osteosarcoma and rhabdomyosarcoma cell lines. in Journal of Cancer Research and Clinical Oncology. https://doi.org/10.1007/s00432-023-04930-9
- Related to published version: https://imagine.imgge.bg.ac.rs/handle/123456789/1918
- Related to accepted verison: https://imagine.imgge.bg.ac.rs/handle/123456789/1928
Povezane informacije:
- Povezani sadržaj
https://imagine.imgge.bg.ac.rs/handle/123456789/1918 - Povezani sadržaj
https://doi.org/10.1007/s00432-023-04930-9 - Povezani sadržaj
https://imagine.imgge.bg.ac.rs/handle/123456789/1928
Institucija/grupa
Institut za molekularnu genetiku i genetičko inženjerstvoTY - DATA AU - Milošević, Emilija AU - Stanisavljević, Nemanja AU - Bošković, Srđan AU - Stamenković, Nemanja AU - Novković, Mirjana AU - Bavelloni, Alberto AU - Cenni, Vittoria AU - Kojić, Snežana AU - Jasnić, Jovana PY - 2023 UR - https://doi.org/10.1007/s00432-023-04930-9 UR - https://imagine.imgge.bg.ac.rs/handle/123456789/1929 T2 - Journal of Cancer Research and Clinical Oncology T1 - Supplementary data for the article: Milošević, E., Stanisavljević, N., Bošković, S., Stamenković, N., Novković, M., Bavelloni, A., Cenni, V., Kojić, S.,& Jasnić, J.. (2023). Antitumor activity of natural pigment violacein against osteosarcoma and rhabdomyosarcoma cell lines. in Journal of Cancer Research and Clinical Oncology. https://doi.org/10.1007/s00432-023-04930-9 UR - https://hdl.handle.net/21.15107/rcub_imagine_1929 ER -
@misc{ author = "Milošević, Emilija and Stanisavljević, Nemanja and Bošković, Srđan and Stamenković, Nemanja and Novković, Mirjana and Bavelloni, Alberto and Cenni, Vittoria and Kojić, Snežana and Jasnić, Jovana", year = "2023", journal = "Journal of Cancer Research and Clinical Oncology", title = "Supplementary data for the article: Milošević, E., Stanisavljević, N., Bošković, S., Stamenković, N., Novković, M., Bavelloni, A., Cenni, V., Kojić, S.,& Jasnić, J.. (2023). Antitumor activity of natural pigment violacein against osteosarcoma and rhabdomyosarcoma cell lines. in Journal of Cancer Research and Clinical Oncology. https://doi.org/10.1007/s00432-023-04930-9", url = "https://hdl.handle.net/21.15107/rcub_imagine_1929" }
Milošević, E., Stanisavljević, N., Bošković, S., Stamenković, N., Novković, M., Bavelloni, A., Cenni, V., Kojić, S.,& Jasnić, J.. (2023). Supplementary data for the article: Milošević, E., Stanisavljević, N., Bošković, S., Stamenković, N., Novković, M., Bavelloni, A., Cenni, V., Kojić, S.,& Jasnić, J.. (2023). Antitumor activity of natural pigment violacein against osteosarcoma and rhabdomyosarcoma cell lines. in Journal of Cancer Research and Clinical Oncology. https://doi.org/10.1007/s00432-023-04930-9. in Journal of Cancer Research and Clinical Oncology. https://hdl.handle.net/21.15107/rcub_imagine_1929
Milošević E, Stanisavljević N, Bošković S, Stamenković N, Novković M, Bavelloni A, Cenni V, Kojić S, Jasnić J. Supplementary data for the article: Milošević, E., Stanisavljević, N., Bošković, S., Stamenković, N., Novković, M., Bavelloni, A., Cenni, V., Kojić, S.,& Jasnić, J.. (2023). Antitumor activity of natural pigment violacein against osteosarcoma and rhabdomyosarcoma cell lines. in Journal of Cancer Research and Clinical Oncology. https://doi.org/10.1007/s00432-023-04930-9. in Journal of Cancer Research and Clinical Oncology. 2023;. https://hdl.handle.net/21.15107/rcub_imagine_1929 .
Milošević, Emilija, Stanisavljević, Nemanja, Bošković, Srđan, Stamenković, Nemanja, Novković, Mirjana, Bavelloni, Alberto, Cenni, Vittoria, Kojić, Snežana, Jasnić, Jovana, "Supplementary data for the article: Milošević, E., Stanisavljević, N., Bošković, S., Stamenković, N., Novković, M., Bavelloni, A., Cenni, V., Kojić, S.,& Jasnić, J.. (2023). Antitumor activity of natural pigment violacein against osteosarcoma and rhabdomyosarcoma cell lines. in Journal of Cancer Research and Clinical Oncology. https://doi.org/10.1007/s00432-023-04930-9" in Journal of Cancer Research and Clinical Oncology (2023), https://hdl.handle.net/21.15107/rcub_imagine_1929 .